Purpose of the Framework
The purpose of the framework is to provide a systematic approach for review of all applicable national guidance, reports and strategies and implementation of recommendations to improve patient care, treatment and safety, reducing risk and enabling service development.
National guidance includes recommendations from NICE (The National Institute for Health and Care Excellence, the National Confidential Enquiries, other national clinical audits and studies from approved bodies e.g. the Royal Colleges. This framework is also relevant for recommendations from major inquiries (such as Laming, Francis) and national strategies e.g. End of Life Care Strategy, Dementia Care Strategy.
The policy encompasses the processes required for the implementation of best practice guidance and recommendations from national reports and publications. This policy applies to all clinical services.
A mechanism supporting implementation of NICE guidance was established at the Trust in 2004; in 2005 this framework was adapted to include all national guidance and was later, further revised to include applicable national publications identified by the Care Quality Commission, CQC.
The Trust is committed to the timely implementation of the recommendations contained within national clinical audits, confidential enquiries and other studies relevant to services provided by the Trust. The General Medical Council states that participation by doctors in the Confidential Enquiries is one of the elements of Good Medical Practice. The NHS Litigation Authority (NHSLA) through the Risk Management Standards requires Trusts to:
‘Have an approved documented process for ensuring that agreed best practice as defined in national confidential enquiries is taken into account in the context of the clinical services provided by the organisation that is implemented and monitored’.
|Compiled by:||Head of Clinical Effectiveness|
|Ratified by:||Clinical Governance Committee|
|Date Ratified:||October 2016|
|Date Issued:||October 2016|
|Review Date:||October 2019|
|Target Audience:||All Clinical Staff|
|Contact name:||Head of Clinical Effectiveness|